Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies

Intravenous immunoglobulin (IVIG) is a potential therapy for chronic inflammatory demyelinating polyneuropathy (CIDP). To investigate the efficacy and safety of the IVIG IgPro10 (Privigen) for treatment of CIDP, results from Privigen Impact on Mobility and Autonomy (PRIMA), a prospective, open‐label...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Peripher Nerv Syst
Autors principals: Merkies, Ingemar S.J., van Schaik, Ivo N., Léger, Jean‐Marc, Bril, Vera, van Geloven, Nan, Hartung, Hans‐Peter, Lewis, Richard A., Sobue, Gen, Lawo, John‐Philip, Durn, Billie L., Cornblath, David R., De Bleecker, Jan L., Sommer, Claudia, Robberecht, Wim, Saarela, Mika, Kamienowski, Jerzy, Stelmasiak, Zbigniew, Tackenberg, Björn, Mielke, Orell
Format: Artigo
Idioma:Inglês
Publicat: Wiley Periodicals, Inc. 2019
Matèries:
Research Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6594229/
https://ncbi.nlm.nih.gov/pubmed/30672091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jns.12302
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars